MeSH D003874 - dermatitis herpetiformis
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
Events Timeline
Commercial
Company Name | Drug Name | Trade Name | Patent Expires | Approval Date | Revenue | Period |
|---|---|---|---|---|---|---|
| Padagis | Dapsone | Dapsone |  | 2023-11-01 |  |  |
| Taro Pharmaceutical | Dapsone | Dapsone |  | 2019-03-01 |  |  |
| Mylan | Dapsone | Dapsone |  | 2022-02-04 |  |  |
| Rising Pharmaceuticals | Dapsone | Dapsone |  | 2019-05-08 |  |  |
| Almirall | Dapsone | Aczone | 2033-11-18 | 2016-02-24 |  |  |
1
2
3
4
5
6
...
14
>
Clinical Trials
Historical Success Rate
Phase 1
0%0/0
Phase 2
0%0/0
Phase 3
100%9/9
Approved: 9Overall Success rate: 0%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name | Phase 1 | Phase 2 | Phase 3 | Phase 4 | Drug Name |
|---|---|---|---|---|---|
1
2
3
4
5
6
...
10
>
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use